To Dance or Not to Dance? Updated Venue Selection Matrices for a Maturing Biosimilar Industry
Steven D. Maslowski
Partner | IP Practice Group Leader
Akin Gump Strauss Hauer & Feld LLP
Peter Sandel
Partner
Groombridge, Wu, Baughman & Stone LLP
- Comparing the different standards of proof in BPCIA, the PTAB, and district courts
- Considering the possibility of multi district litigation
- Reviewing preliminary injunctions and the concept of irreparable harm
- Understanding how irrepealable harm is being quantified, and how it plays out in multiple markets, patents, and patent families
- Overcoming the hurdles created by the sealing process in district courts
- Learning the newest strategies relating to assessing scope:
- E.g., whether to sue everything or whittle down the patents?